Cargando…

Intensified Multifactorial Intervention in Patients with Type 2 Diabetes Mellitus

In the management of diabetes mellitus, one of the most important goals is to prevent its micro- and macrovascular complications, and to that end, multifactorial intervention is widely recommended. Intensified multifactorial intervention with pharmacotherapy for associated risk factors, alongside li...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sasako, Takayoshi, Yamauchi, Toshimasa, Ueki, Kohjiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Diabetes Association 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10040617/ https://www.ncbi.nlm.nih.gov/pubmed/36631991 http://dx.doi.org/10.4093/dmj.2022.0325

Ejemplares similares

Effect of a Multifactorial Intervention on Fracture in Patients With Type 2 Diabetes: Subanalysis of the J-DOIT3 Study
por: Sasako, Takayoshi, et al.
Publicado: (2021)

Sarcopenia: Loss of mighty armor against frailty and aging
por: Sasako, Takayoshi, et al.
Publicado: (2023)

Perspective of Small-Molecule AdipoR Agonist for Type 2 Diabetes and Short Life in Obesity
por: Okada-Iwabu, Miki, et al.
Publicado: (2015)

Cost-Effectiveness of Intensified Versus Conventional Multifactorial Intervention in Type 2 Diabetes: Results and projections from the Steno-2 study
por: Gæde, Peter, et al.
Publicado: (2008)

Adaptive Response as a Potential Key Link Between SGLT2 Inhibition and Renoprotection
por: Sasako, Takayoshi, et al.
Publicado: (2021)

Primary Prevention of Macroangiopathy in Patients With Short-Duration Type 2 Diabetes by Intensified Multifactorial Intervention: Seven-year follow-up of diabetes complications in Chinese
por: Yang, Yu, et al.
Publicado: (2013)

Retrospective nationwide study on the trends in first‐line antidiabetic medication for patients with type 2 diabetes in Japan
por: Bouchi, Ryotaro, et al.
Publicado: (2021)

Psychological and behavioural patterns of stigma among patients with type 2 diabetes: a cross-sectional study
por: Kato, Asuka, et al.
Publicado: (2017)

How self-stigma affects patient activation in persons with type 2 diabetes: a cross-sectional study
por: Kato, Asuka, et al.
Publicado: (2020)

Preparation and culture of bone marrow-derived macrophages from mice for functional analysis
por: Toda, Gotaro, et al.
Publicado: (2020)

Association between self-stigma and self-care behaviors in patients with type 2 diabetes: a cross-sectional study
por: Kato, Asuka, et al.
Publicado: (2016)

Reduced risk of heart failure with intensified multifactorial intervention in individuals with type 2 diabetes and microalbuminuria: 21 years of follow-up in the randomised Steno-2 study
por: Oellgaard, Jens, et al.
Publicado: (2018)

Associations between diabetes duration and self-stigma development in Japanese people with type 2 diabetes: a secondary analysis of cross-sectional data
por: Kato, Asuka, et al.
Publicado: (2021)

Efficacy, safety and tolerability of imeglimin in patients with type 2 diabetes mellitus: A meta‐analysis of randomized controlled trials
por: Hagi, Katsuhiko, et al.
Publicado: (2023)

Maturity‐onset diabetes of the young as a model for elucidating the multifactorial origin of type 2 diabetes mellitus
por: Horikawa, Yukio
Publicado: (2018)

Deletion of skeletal muscle Akt1/2 causes osteosarcopenia and reduces lifespan in mice
por: Sasako, Takayoshi, et al.
Publicado: (2022)

Randomized trial of an intensified, multifactorial intervention in patients with advanced‐stage diabetic kidney disease: Diabetic Nephropathy Remission and Regression Team Trial in Japan (DNETT‐Japan)
por: Shikata, Kenichi, et al.
Publicado: (2020)

Progress in genetics of type 2 diabetes and diabetic complications
por: Shojima, Nobuhiro, et al.
Publicado: (2023)

Effect of patient characteristics on the efficacy and safety of imeglimin monotherapy in Japanese patients with type 2 diabetes mellitus: A post‐hoc analysis of two randomized, placebo‐controlled trials
por: Hagi, Katsuhiko, et al.
Publicado: (2023)

A cost analysis of intensified vs conventional multifactorial therapy in individuals with type 2 diabetes: a post hoc analysis of the Steno-2 study
por: Gæde, Joachim, et al.
Publicado: (2018)

Beneficial impact of intensified multifactorial intervention on risk of stroke: outcome of 21 years of follow-up in the randomised Steno-2 Study
por: Gæde, Peter, et al.
Publicado: (2019)

Lung abscess without sepsis in a patient with diabetes with refractory episodes of spontaneous hypoglycemia: a case report and review of the literature
por: Toda, Gotaro, et al.
Publicado: (2014)

A Multifactorial Risk Score System for the Prediction of Diabetic Kidney Disease in Patients with Type 2 Diabetes Mellitus
por: Hui, Dongna, et al.
Publicado: (2023)

Severe aortic stenosis during leptin replacement therapy in a patient with generalized lipodystrophy‐associated progeroid syndrome due to an LMNA variant: A case report
por: Sasako, Takayoshi, et al.
Publicado: (2022)

Years of life gained by multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: 21 years follow-up on the Steno-2 randomised trial
por: Gæde, Peter, et al.
Publicado: (2016)

Left Hemiplegia Possibly Due to Glucose Reperfusion Injury after Recovery of Severe Hypoglycemia in a Woman with Type 2 Diabetes Mellitus
por: Sugito, Erika, et al.
Publicado: (2021)

Impacts of tight multifactorial intervention in patients with type 2 diabetes: Implications from the Japan Diabetes Outcome Intervention Trial 3
por: Araki, Eiichi, et al.
Publicado: (2018)

Long‐term safety and efficacy of exenatide twice daily in Japanese patients with suboptimally controlled type 2 diabetes
por: Inagaki, Nobuya, et al.
Publicado: (2011)

Contribution of pancreatic α‐cell function to insulin sensitivity and glycemic variability in patients with type 1 diabetes
por: Takahashi, Nobuyuki, et al.
Publicado: (2018)

The Multifactorial Progression from the Islet Autoimmunity to Type 1 Diabetes in Children
por: Bauer, Witold, et al.
Publicado: (2021)

Efficacy and safety of imeglimin in Japanese patients with type 2 diabetes: A 24‐week, randomized, double‐blind, placebo‐controlled, dose‐ranging phase 2b trial
por: Dubourg, Julie, et al.
Publicado: (2021)

Effectiveness of A Multifactorial Intervention in Increasing Adherence to the Mediterranean Diet among Patients with Diabetes Mellitus Type 2: A Controlled and Randomized Study (EMID Study)
por: Alonso-Domínguez, Rosario, et al.
Publicado: (2019)

Gut insulin action protects from hepatocarcinogenesis in diabetic mice comorbid with nonalcoholic steatohepatitis
por: Soeda, Kotaro, et al.
Publicado: (2023)

Continuous low serum levels of advanced glycation end products and low risk of cardiovascular disease in patients with poorly controlled type 2 diabetes
por: Nakamura, Tomoka, et al.
Publicado: (2023)

Downregulation of macrophage Irs2 by hyperinsulinemia impairs IL-4-indeuced M2a-subtype macrophage activation in obesity
por: Kubota, Tetsuya, et al.
Publicado: (2018)

Multifactorial intervention for diabetes control among older users of insulin
por: Machry, Rafael Vaz, et al.
Publicado: (2018)

Effects of efforts to intensify management on blood pressure control among patients with type 2 diabetes mellitus and hypertension: A pilot study
por: DeJesus, Ramona S, et al.
Publicado: (2009)

BeAM value: an indicator of the need to initiate and intensify prandial therapy in patients with type 2 diabetes mellitus receiving basal insulin
por: Zisman, Ariel, et al.
Publicado: (2016)

Sarcopenia phenotype and impaired muscle function in male mice with fast-twitch muscle-specific knockout of the androgen receptor
por: Hosoi, Tatsuya, et al.
Publicado: (2023)

Design of and rationale for the Japan Diabetes Optimal Integrated Treatment study for 3 major risk factors of cardiovascular diseases (J-DOIT3): a multicenter, open-label, randomized, parallel-group trial
por: Ueki, Kohjiro, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_lik42pglahh79bq5ehq42kmvqn